{"disease":{"id":"sickle-cell-nephropathy","name":"sickle cell nephropathy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06065852","title":"National Registry of Rare Kidney Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":35000,"lead_sponsor_name":"UK Kidney Association","has_results":false},{"nct_id":"NCT03680547","title":"Nephropathy in Patients With Sickle Cell Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":25,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT04335721","title":"A Voxelotor for Sickle Cell Anemia Patients at Highest Risk for Progression of Chronic Kidney Disease","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"University of Illinois at Chicago","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}